Mode
Text Size
Log in / Sign up

Olfactory decline associated with conversion to mild cognitive impairment and dementia in unimpaired adultsLosing your sense of smell might warn of memory loss

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize olfactory decline associates with MCI conversion risk in this retrospective cohort without establishing causality.

This retrospective longitudinal analysis utilized data from the Arizona Study of Aging and Neurodegenerative Disorders involving 922 cognitively unimpaired individuals without parkinsonism. The study tracked participants over a mean follow-up of 7.7 (5.4) years to assess olfactory decline as an exposure.

Olfactory function was significantly reduced in converters compared to non-converters with a t-value of -12.6 and p <0.0001. Converters also demonstrated faster progression in neuropsychiatric symptom burden (t=3.42, p < 0.001) and faster memory decline (t= -7.33, p<0.0001). Motor scores showed no significant differences between groups.

Prediction accuracy for conversion to MCI reached ~ 70% when combining olfactory decline, neuropsychiatric burden, motor, and memory decline. Using the UPSIT alone yielded ~ 60% accuracy. Higher alpha-synuclein burden (t= -8.21, p<0.0005), Tau tangle burden (t= -2.66, p < 0.01), and Amyloid plaque burden (t= -2.85, p <0.005) were associated with longitudinal decline in olfaction. Tau burden (t=5.66, p<0.0001) associated with faster decline.

Safety data were not reported. The study design is retrospective, indicating association rather than causation. Incorporating olfactory testing in cognitively unimpaired individuals may help identify those at risk of future cognitive decline.

Imagine waking up one morning and realizing you cannot smell your morning coffee. That simple loss might signal something much bigger happening inside your brain.

Many people dismiss a bad sense of smell as just getting older. They do not realize it could be an early warning sign.

Smell loss signals brain changes early

Millions of older adults worry about memory loss every single day. Alzheimer's disease often starts silently without any obvious symptoms. Current tests usually wait until memory slips happen to make a diagnosis.

This delay means doctors miss the chance to help people early. By the time memory fades, the damage inside the brain is already significant.

Researchers looked at a different path to find the answer. They focused on the nose instead of just the memory.

How the nose links to memory

Think of the brain like a factory that makes important chemicals. Chemical waste builds up before the machines break down completely. Smell nerves are often the first to feel this damage.

The study followed 922 people for nearly eight years. They started with healthy adults who had no memory problems.

Over time, some participants lost their ability to identify scents. Those people later developed mild cognitive impairment or dementia.

This does not mean every person with smell loss will get dementia.

The drop in smell happened years before the memory issues started. It was a clear signal that something was wrong inside the head.

Why accuracy matters for early care

The researchers found that smell loss predicted conversion with high accuracy. They combined smell tests with other checks to get the best results.

This combination predicted memory decline about 70 percent of the time. Smell tests alone predicted it about 60 percent of the time.

But there is a catch.

This accuracy is not perfect enough to diagnose everyone on its own. It works best when used alongside other medical checks.

Experts say this adds a new tool to the medical kit. It helps spot risk before symptoms get severe enough to worry.

What happens next for patients

You should talk to a doctor if you notice changes in your nose. Do not panic over a bad cold or allergies.

The study group was specific to this research project. It needs more work before becoming a standard rule for everyone.

More trials will test if testing helps people live longer. Science moves slowly but surely to find the truth.

Doctors are learning how to use smell tests to track brain health. This could change how we check for Alzheimer's in the future.

The goal is to catch problems early when treatments might work better. Waiting for memory loss to happen is no longer the only option.

Researchers continue to study how smell connects to brain disease. They hope to find ways to stop the decline before it starts.

For now, paying attention to your senses is a smart step. It is one more way to take care of your brain health.

Study Details

Study typeCohort
Sample sizen = 922
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Importance: Decline in olfactory function may be used as a predictor of cognitive decline, to enhance early detection models, improve risk stratification, and enable early intervention. Objective: To assess the longitudinal association between olfactory decline, cognitive decline, and postmortem neuropathology. Design, setting and participants: Retrospective longitudinal analysis with clinicopathological correlations of a prospective population-based cohort study using data from the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND) and its Brain and Body Donation Program. Participants included cognitively unimpaired individuals without parkinsonism that converted to mild cognitive impairment (MCI) and/or dementia or remained cognitively stable. Main Outcomes and Measures: longitudinal change in olfaction, neuropsychiatric symptoms, motor function and memory, conversion to MCI/dementia, postmortem neuropathology Results: Over a mean follow-up period of 7.7 (5.4) years, out of 922 participants who were cognitively unimpaired at the first cognitive conference, 643 remained cognitively unimpaired, 279 converted to MCI, and 82 developed dementia. Of these, 633 individuals had at least 2 olfactory tests. Converters showed reduced olfactory function (t=-12.6, p <0.0001), faster progression in neuropsychiatric symptom burden (t=3.42, p < 0.001), and faster decline in memory (t= -7.33, p <0.0001) prior to conversion while no significant differences were observed in motor scores between converters and non-converters. Using ROC analysis, olfactory decline, increased neuropsychiatric symptom burden, as well as motor and memory decline predicted conversion to MCI with a consistent accuracy of ~ 70% up to 5 years before conversion, while UPSIT alone had an accuracy of ~ 60%. Longitudinal decline in olfaction was associated with a higher burden of a-synuclein (t= -8.21, p <0.0005), tau tangle (t= -2.66, p < 0.01) and amyloid plaque burden (t= -2.85, p < 0.005) and a faster decline over time was associated with a higher burden of tau (t=5.66, p<0.0001). Conclusions and Relevance: A reduction in olfactory identification ability is observed up to a decade prior to conversion to MCI and is associated with underlying burden of neuropathology markers, underscoring the value of incorporating olfactory testing in cognitively unimpaired individuals to identify those at-risk of future cognitive decline.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.